GLPwatch
Trials (2167)
Page 25 of 37.
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
- A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
- Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
- Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss
- Tirzepatide and Muscle Outcomes in Obesity
- Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
- The Medically Reproducing Bariatric Surgery (MRB) II Study
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
- Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
- A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
- A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
- Proof of Concept Study in Patients With Short Bowel Syndrome
- The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Comparison of Two Liraglutide Formulations in Healthy Subjects
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
- Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
- Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
- The Long COVID Treatment Trial
- Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
- Comparison of Type 2 Diabetes Pharmacotherapy Regimens
- Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
- Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
- A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
- Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
- Effect Of Semaglutide In Coronary Atheroma Plaque
- The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
- A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
- A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
- Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
- Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease
- Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
- A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
- A Study of HS-20094 in T2DM Participants
- Exeantide in Type 2 Diabetes on Insulin
- IDegLira HIGH Trial
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
- Study on Lixisenatide and Counterregulation to Hypoglycemia
- A Study to Evaluate ALN-2232 in Participants With Obesity
- Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
- The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
- Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
- GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
- Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
- The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
- Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
- Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Fibrosis Lessens After Metabolic Surgery
- A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
- Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial
- Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes
- Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure
- A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight